Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
40 Cards in this Set
- Front
- Back
|
lidocane hydrochloride
other name |
Xylocaine
|
|
|
lidocane hydrochloride
Class |
Antiarrythmeic
|
|
|
lidocane hydrochloride
mechanism of action |
decreases automacity by slowing the rate oof phase 4 depolarization
|
|
|
lidocane hydrochloride
indicatons |
alt. to amiodarone in cardiac arrest from v-fid /pulseless v-tach, stable monomorphic v-tach, stable polymorphic v-tach with normal baseline QT interval
|
|
|
lidocane hydrochloride
contraindications |
hypersensitivity, 2nd and 3rd degree AV blocks in the absense of atrial pacemaker, stokes-adams syndrome, prophylactic use in AMI, wide-complex ventricular escape beats with brady
|
|
|
lidocane hydrochloride
adverse reactions |
slurred speach, seizures (with high dose) altered mental status, confusion, lightheadedness, blurred vision, brady
|
|
|
lidocane hydrochloride
drug interactions |
apnea induced succinlcholine may prolonged with high dose of lidocaine. Cardiac depression may occur in conjunction with IV phenytoin (dilantin). Procainamide may exasterbate CNS effects. metabilic clearance is decreased in patients with lever disease or in patients taking beta blockers
|
|
|
lidocane hydrochloride
how supplied |
100mg in 5ml prefilled syrinfges and mpules(20ml)
1g and 2g additive syringes, 1 and 2 gram vials in 30ml solution |
|
|
lidocane hydrochloride
ADULT dosages and administration |
cardiac arrest from v-fib or pulseless v-tach: initial 1-1.5mg/k IV/IO push. repeat .5 to .75 mg/k in 5 to 10 min.
-Max dose of 3mg. -ET dose: 2 to 4mg/K -stable v-tach, wide- complex tach of uncertain type. significant ectopy: .5 to .75mg/K and up to 1 to 1.5mg/K may be used. Rpt. .5 to .75 every 5 to 10 min |
|
|
lidocane hydrochloride
duration of action |
onset: 1 to 3 min
peak: 5 to 10 min duration: 15min to 2 hours |
|
|
morphine sulfate
other names |
astramorph/PF and others
|
|
|
morphine sulfate
class |
opioid analegesic (schedule 2 marcotic)
|
|
|
morphine sulfate
mechanism of action |
alleviates pain through CNS action, suppresses fear and anxiety centers in the brain. depresses brain stem respiratory centers, increases peripheral venus capacitance and decreases venus return, decreases preload and afterload, which decreases myocardial oxygen demad
|
|
|
morphine sulfate
indication |
Severe CHF, pulmonary edema, chest pain associated with AMI, analgesia for moderate to severe acute and chronic pain (use with caution)
|
|
|
morphine sulfate
contraindications |
head injury, exacerbated COPD, depressed respiratory level, hypotension, undiagnosed abdominal pain, decreased level of consciousness, suspected hypovolemia, pts who have taken MAOIs in the past 14 days
|
|
|
morphine sulfate
adverse reactions |
respiratory depression, hypotension, decreased LOC, nausea, emesis, brady, tachy, syncope, facial flushing, euphoria, bronchospasm, dry mouth
|
|
|
morphine sulfate
drug interactions |
potentiates sedative effects of phenothiazines CNS depressant may potentiate effects of morphine. MAOIs may cause pardoxial excitation
|
|
|
morphine sulfate
how supplied |
10mg in 1mL of solution, ampules and tubex syringes
|
|
|
morphine sulfate
ADULT dosages and administration |
initial dose: 2-4mg IV(over 1 ro 5 min) every 5 to 30min. rpt dose 2-8mg at 5 to 15min intervals
|
|
|
morphine sulfate
Duration of action |
onset: immediate
peak: 20min duration 2-7 hours |
|
|
Furosemide
other names |
Lasix
|
|
|
Furosemide
class |
loop diuretic
|
|
|
Furosemide
mechanism of action |
inhibits electrolyte reasorbtion and promotes excretion of NA, K, and Chloride
|
|
|
Furosemide
indications |
CHF, pulmonary edema, HTN crisis
|
|
|
Furosemide
Contraindication |
hypovolemia, anuria, hypotension (relative contraindication), hypersensitivity, hepatic coma
|
|
|
Furosemide
adverse reactions |
may exerstabate hyovolenia, hypokalemia, ECG changes, dry mouth, hypochloremia, hyponateremia, hypergylcemia (due to hemoconcentration)
|
|
|
Furosemide
Drug interaction |
Lithum toxicity may be potentiated by sodium depletion, digitalis toxicity may be potentiated by K+ depletion
|
|
|
Furosemide
How supplied |
100mg/5mL, 20mg/2mL, 40mg/4mL vials
|
|
|
Furosemide
ADULT dosage and administration |
.5 to 1.0 mg/k injjected IV over 1 to 2 min. if no response double the dose to 2mg/K over 1 to 2 min
|
|
|
Furosemide
duration of action |
onset: 5min
peak: 20 to 60 min duration: 4 to 6 hours |
|
|
Nitroglycerine
other names |
nitrostat, tridil
|
|
|
Nitroglycerine
class |
vasodilator
|
|
|
Nitroglycerine
mechanism of action |
smooth muscle relaxant acting on vasuclar, bronchial, and intestinal smooth muscle; dilation of arterioles and veins in the periphery; reduces preload and afterload, decreases the work load of the heart and theyby myocardial oxygen demand
|
|
|
Nitroglycerine
indications |
acute angina pectoris, ischemic chest pain, hypotension, CHf, pulmonary edema
|
|
|
Nitroglycerine
contraindications |
hypotension, hypovolemia, intracranial bleeding or head injury, previous admin of viagra, revatio, levitra cialis or simular agenst with in 24 hrs.
|
|
|
Nitroglycerine
adverse reactions |
headache, hypotension, syncope, reflex tachycardia, nausea, emesis, diaphoresis, muscle twitching
|
|
|
Nitroglycerine
drug interactions |
additive effects with other vasodilators; incompatible with other IV drugs
|
|
|
Nitroglycerine
How supplied |
tablets : .15mg; .3mg, .4mg, .6mg
NTG spray .4mg-.8mg under the tongue TG IV |
|
|
Nitroglycerine
Duration of action |
onset 1 to3 min
peak: 5 to 10 min duration: 20 to 30 min :IF IV 1-10 min after discontinuation of infusion |
|
|
Nitroglycerin
ADULT dose and administration |
tablets: .3 or .4mg SL rpt 3 to5min max 3 doses, NTG spray .4 SL 1 to 2 sprays. NTG IV - 10 to 20μg/min every 5min until desired effect.
|
